News

imaGenes will provide service offerings with BioTrove’s OpenArray Platform, a nanoliter Real-Time qPCR, allowing for about 9,000 assays simultaneously. Reportedly, OpenArray produces faster results, allowing gene expression profiling,

InVitria has launched Optiferrin, a high performance, well-defined and animal-free recombinant transferrin for use in mammalian cell culture. Optiferrin is a cell culture supplement which supports cell growth

APP Pharmaceuticals, a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals, has received approval from the FDA to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine

Genentech has announced that a phase III study (PRIMA) showed that patients with follicular lymphoma who continued receiving Rituxan (rituximab) alone after responding to Rituxan and chemotherapy lived

The FDA has Novartis’ approved Valturna (aliskiren and valsartan) tablets, a medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone

Schiff Nutrition International has reported a net sales of $48.6m for the three months ended August 31, 2009, an increase when compared to $47.8m for the same period

Bolder BioTechnology (Bolder) has been awarded a $1.2m phase II Small Business Innovation Research (SBIR) grant, entitled ‘Long-Acting EPO Analog for Treating Anemia Associated with Chronic Kidney Disease,’

Merial has licensed the Clean Genome E coli developed by Scarab Genomics for commercial production of an upcoming veterinary vaccine. Reportedly, Clean Genome E coli are K-12 strains,

A new study conducted by Thomas Shea and his team of scientists demonstrated that MemoryXL previously shown to improve cognitive performance in Alzheimer’s disease on adults without dementia.